Table 3.
Analysis of HBV genotypes between HIV-positive and HIV-negative groups
| HBV genotype | Current study (N = 28) | Nationwide (N = 720)* | Statistical significance† | ||||
|---|---|---|---|---|---|---|---|
| Total no. of cases | (%) | HIV positive (N = 15) | HIV negative (N = 13) | No. of cases | (%) | ||
| A (Aa/Ae) | 15 | (53·6) | 9 (0/9) | 6 (1/5) | 12 | (1·7) | P <0·001 |
| B | 0 | (0) | 0 | 0 | 88 | (12·2) | n.s. |
| C | 9 | (32·1) | 3 | 6 | 610 | (84·7) | P <0·001 |
| D | 0 | (0) | 0 | 0 | 3 | (0·4) | n.s. |
| G | 3 | (10·7) | 3 | 0 | 0 | (0) | P <0·001 |
| Mixed | 0 | (0) | 0 | 0 | 7 | (1) | n.s. |
| Unknown | 1 | (3·6) | 0 | 1 | 0 | (0) | n.s. |
n.s., Not significant.
*
Orito et al. [29].
†
χ2 test between current study (total) and nationwide survey.